Cryoprecipitated Antihemophilic Factor
Cryoprecipitate from fresh frozen plasma containing Factor VIII, fibrinogen, and von Willebrand factor for therapeutic clotting support. Under HTS 3002.90.52 as other animal/human blood products prepared for therapeutic uses. Commonly used in surgical bleeding management.
Import Duty Rates by Country of Origin
More Specific Codes
This product may fall under a more specific subheading:
Alternative Classifications
This product could be classified differently depending on its characteristics or intended use.
Not sure which classification is right?
Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.
Import Tips & Compliance
• Ensure donor screening records accompany shipment to verify safety from blood-borne pathogens
• Classify based on primary therapeutic fraction; avoid bulk plasma categorization
• Coordinate with CBP for prior notice under Bioterrorism Act for human blood products
Related Products under HTS 3002.90.52
Human Serum Albumin 20% Solution
A sterile solution of human serum albumin at 20% concentration, prepared from human plasma for therapeutic use in treating hypovolemia and shock. It falls under HTS 3002.90.52 as a blood fraction prepared for therapeutic uses. This product is biotechnologically processed to ensure purity and safety.
Anti-Hemophilic Factor VIII Concentrate
A lyophilized concentrate of coagulation Factor VIII derived from human plasma, used therapeutically for hemophilia A treatment. Classified under HTS 3002.90.52 as an other blood fraction prepared for therapeutic uses via biotechnological purification. It replaces missing clotting factors in patients.
IVIG Intravenous Immunoglobulin
A pooled immunoglobulin G preparation from human plasma for intravenous administration in immunodeficiency disorders. HTS 3002.90.52 covers it as other blood fractions prepared for therapeutic uses. Biotechnological processes ensure high purity and immune modulation.
Monoclonal Antibody Infusion for Cancer Therapy
Biotechnologically produced monoclonal antibodies like rituximab for therapeutic infusion in lymphoma treatment. HTS 3002.90.52 includes such immunological products prepared for therapeutic uses. They target specific cancer cells via immune regulation.
Botulism Antitoxin Serum
Equine-derived antiserum containing antibodies against botulinum toxin for therapeutic treatment of botulism poisoning. Classified in HTS 3002.90.52 as other antisera prepared for therapeutic uses. Essential for emergency prophylactic administration.
Rh Immune Globulin Injection
Human anti-D immunoglobulin for prophylactic prevention of Rh hemolytic disease in newborns. HTS 3002.90.52 as other blood fractions and immunological products for prophylactic uses. Administered to Rh-negative mothers post-delivery.